AlphAIalphai — Financial news for AI agents
富途牛牛MAY 12 min read$GRWG

GrowGeneration Announces First Quarter 2026 Earnings Release Conference Call for May 12, 2026

GrowGeneration Corp. announced it will release its first quarter 2026 financial results after market close on Monday, May 11, 2026. The company will host a conference call the following day, Tuesday, May 12, 2026, at 8:00 a.m. EDT to discuss the results and provide a business update. Investors can access the live webcast via the company's IR website or listen by phone.

Original reporting
富途牛牛
Published May 1, 2026, 11:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 1, 2026, 11:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$GRWG
Neutral
medium confidence
Mentioned
$GRWG
alphai data visualization · based on 富途牛牛
Decision brief

The 30-second read

$GRWGNeutralLow
01

Why it matters

Earnings releases are key catalysts that can cause short-term volatility; the neutral sentiment suggests limited immediate impact unless results differ markedly from expectations.

02

Market read

The event is relevant primarily to investors holding or considering positions in GrowGeneration; broader market impact is limited.

03

What to watch

Market reaction may be influenced by broader macroeconomic conditions or sector-specific news unrelated to earnings.

Timing: short-term

Background

GrowGeneration is scheduled to release its Q1 2026 financial results on May 11, 2026, followed by a conference call on May 12, 2026, to discuss the results and provide updates.

Company-level read

Ticker impact

$GRWGNeutralMedium confidence
Context

The upcoming earnings release is a scheduled event that may influence short-term trading activity.

Expected impact

Potential for minor volatility post-earnings; no clear directional bias.

Evidence & confidence

Earnings announcements typically influence stock prices, but current sentiment is neutral, and no preliminary guidance suggests significant surprises.

Market effects

Sector

The earnings report may influence sector peers if results are notably better or worse than industry benchmarks.

Regional

Limited regional impact; primarily affecting investors in North America.

Global

Minimal global market relevance given the company's regional focus and neutral sentiment.

Counterpoint

What could challenge this read

If earnings significantly beat expectations, the stock could experience a sharp upward move, presenting a short-term trading opportunity.

Key entities

  • Company
    GrowGeneration Corp.

    A company involved in the cultivation and retail of hydroponic and organic gardening products.

Read at source← All news

Related articles

AUG 14
$GRWGMedAI 8/10

GrowGeneration Beats on Q2 Earnings, Hikes '26 Adjusted EBITDA View

GrowGeneration Corp. (GRWG) reported Q2 2026 results: a 3-cent per-share loss, narrower than the Zacks Consensus estimate of a 4-cent loss and versus an 8-cent loss a year earlier. Sales rose 5.5% to $43.2M. Adjusted EBITDA was $0.3M. The company raised full-year adjusted EBITDA guidance to $2–$3M and reaffirmed sales guidance of $162–$168M.

tradingview.com4 min
AUG 13
$GRWGMedAI 8/10

GrowGeneration Corp. Q2 2026 Earnings Call Summary

GrowGeneration Corp. reported a third straight quarter of YoY revenue growth, citing a shift to a commercial B2B platform and proprietary brands. Proprietary brand penetration reached 40% ahead of schedule. The company cut store and operating expenses 22% YoY and raised full-year 2026 adjusted EBITDA guidance to $2M-$3M, aided by expected Q3 IEPA tariff refunds. It repurchased 700,000 shares at $1.38.

yahoo.com7 min
AUG 12
$GRWGMedAI 8/10

GrowGeneration (GRWG) Q2 2026 Earnings Call Transcript

GrowGeneration (GRWG) reported Q2 2026 revenue of $43.2 million, up 5.5% year over year, with adjusted EBITDA of $0.3 million versus a $1.3 million loss a year earlier. Net loss narrowed to $2.0 million. Gross margin rose to 28.5%. Full-year 2026 guidance: revenue $162-$168 million and adjusted EBITDA $2-$3 million. Cash was $41 million with no debt.

fool.com6 min
SEP 8
$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

yahoo.com3 min
SEP 8
$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

theyeshivaworld.com2 min
SEP 8
$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.

yahoo.com2 min